Chlamydia trachomatis-specific human CD8+ T cells show two patterns of antigen recognition

被引:12
作者
Matyszak, MK [1 ]
Gaston, JSH [1 ]
机构
[1] Univ Cambridge, Clin Sch, Dept Med, Addenbrookes Hosp, Cambridge CB2 2QQ, England
关键词
D O I
10.1128/IAI.72.8.4357-4367.2004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chlamydia trachomatis is an intracellular gram-negative bacteria which causes several clinically important diseases. T-cell-mediated immunity and the production of gamma interferon (IFN-gamma) are known to be essential for the clearance of the bacteria in vivo. Here we have investigated CD8(+)-T-cell responses to C. trachomatis in patients with previous episodes of chlamydia infection. To isolate C. trachomatis-specific CD8(+)-T-cell lines, dendritic cells (DC) were infected with C. trachomatis and cocultured with purified CD8(+) T cells to generate C. trachomatis-specific CD8(+)-T-cell lines which were then cloned. Two patterns of recognition of C. trachomatis-infected cells by CD8(+)-T-cell clones were identified. In the first, C. trachomatis antigens were recognized in association with classical class I HLA antigens, and responses were inhibited by class I HLA-specific monoclonal antibodies. The second set of clones was unrestricted by classical HIA class I, and further studies showed that CD1 molecules were also not the restriction element for those clones. Both types of clones produced IFN-gamma in response to C. trachomatis and were able to lyse C. trachomatis-infected target cells. However, unrestricted clones recognized C. trachomatis-infected cells at much earlier time points postinfection than HLA-restricted clones. Coculture of C. trachomatis-infected DC with the C. trachomatis-specific clones induced DC activation and a rapid enhancement of interieukin-12 (IL-12) production. Early production of IL-12 during C. trachomatis infection, facilitated by unrestricted CD8(+)-T-cell clones, may be important in ensuring a subsequent Th1 T-cell-mediated response by classical major histocompatibility complex-restricted CD4(+) and CD8(+) T cells.
引用
收藏
页码:4357 / 4367
页数:11
相关论文
共 55 条
[21]   Molecular mechanism of T-cell control of Chlamydia in mice: Role of nitric oxide in vivo [J].
Igietseme, JU .
IMMUNOLOGY, 1996, 88 (01) :1-5
[22]   Chlamydia and associated arthritis [J].
Inman, RD ;
Whittum-Hudson, JA ;
Schumacher, HR ;
Hudson, AP .
CURRENT OPINION IN RHEUMATOLOGY, 2000, 12 (04) :254-262
[23]   Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response [J].
Johansson, M ;
Schon, K ;
Ward, M ;
Lycke, N .
INFECTION AND IMMUNITY, 1997, 65 (03) :1032-1044
[24]   Studies in knockout mice reveal that anti-chlamydial protection requires TH1 cells producing IFN-γ:: Is this true for humans? [J].
Johansson, M ;
Schön, K ;
Ward, M ;
Lycke, N .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1997, 46 (06) :546-552
[25]   Direct detection and magnetic isolation of Chlamydia trachomatis major outer membrane protein-specific CD8+ CTLs with HLA class I tetramers [J].
Kim, SK ;
Devine, L ;
Angevine, M ;
DeMars, R ;
Kavathas, PB .
JOURNAL OF IMMUNOLOGY, 2000, 165 (12) :7285-7292
[26]  
Kim SK, 1999, J IMMUNOL, V162, P6855
[27]   Recognition of chlamydial antigen by HLA-B27-restricted cytotoxic T cells in HLA-B*2705 transgenic CBA (H-2(k)) mice [J].
Kuon, W ;
Lauster, R ;
Bottcher, U ;
Koroknay, A ;
Ulbrecht, M ;
Hartmann, M ;
Grolms, M ;
Ugrinovic, S ;
Braun, J ;
Weiss, EH ;
Sieper, J .
ARTHRITIS AND RHEUMATISM, 1997, 40 (05) :945-954
[28]   Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection [J].
Lampe, MF ;
Wilson, CB ;
Bevan, MJ ;
Starnbach, MN .
INFECTION AND IMMUNITY, 1998, 66 (11) :5457-5461
[29]   Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells:: Definition of antigenic specificity [J].
Lewinsohn, DM ;
Zhu, LQ ;
Madison, VJ ;
Dillon, DC ;
Fling, SP ;
Reed, SG ;
Grabstein, KH ;
Alderson, MR .
JOURNAL OF IMMUNOLOGY, 2001, 166 (01) :439-446
[30]  
Lo WF, 1999, J IMMUNOL, V162, P5398